Tanguy Artz1, Daniel Curnier2, and Delphine Perie1
1Polytechnique Montreal, Montreal, QC, Canada, 2Université de Montréal, Montreal, QC, Canada
Synopsis
This study aims to discriminate three risk groups of leukemia survivors
investigating subtle changes in their myocardium mechanical properties. Volumes extracted from cine-MRI images coupled to
incremental exercise data allowed the quantification of the mechanical
properties of the left ventricle using a reverse material identification
approach based on the CircAdapt model. While both passive and active properties
did not show significant changes in ALL survivors between risk groups, the
increased arteriovenous pressure drop suggested that the cardioprotective agent
entailed a compensation of the cardiac function through the peripheral
components of the oxygen delivery chain.
Introduction
Acute Lymphoblastic Leukemia (ALL) is currently treated using
doxorubicin-based chemotherapy, which effectiveness has been proven [1]. However, it
induces a wide spectrum of dose-dependent cardiotoxicity [2] affecting the
myocardium at both morphological and functional levels. The mechanical
properties of the myocardium could be adequate indicators of the tissue’s
viability. Reverse identification methods based on MRI, intraventricular pressure
measurements and finite element models were proposed but the pressure measured
by catheter cannot be considered in children. The parameterized numerical model
CircAdapt, which enables live simulation of the interaction between the
different walls of the myocardium [3], can be
associated to exercise tests to personalize tissue’s properties. The objective
of this study was to characterize subtle changes in the mechanical properties
of the left ventricle in a cohort of childhood ALL survivors according to their
prognostic risk using the CircAdapt model combined to exercise tests data and
cine-MRI images.Methods
Forty-seven ALL survivors (23±6 years old) were
prospectively included and divided into 3 groups according to their exposition risk
to doxorubicin: standard risk (SR, n=14), high risk (HR, n=17) and high-risk
group who received dexrazoxane, a cardioprotective agent (HRdex, n=16). They
all experienced an
incremental exercise test (cycle ergometer, Oxycon Pro, Jaeger) coupled with
cardiac hemodynamic monitoring (PhysioFlow, Manatec Biomedical). The four basic
inputs of the CircAdapt model were evaluated: heart rate (HR), cardiac output
(CO), diastolic arterial pressure (DAP) and systolic arterial pressure (SAP). All the ALL survivors underwent a CMR
acquisition including an ECG-gated cine TruFISP sequence at 3T (Siemens
SkyraTM) using an 18-channel phased array body matrix coil. For each slice (14
slices in short axis and 4 slices in long axis), 25 phases of the cardiac cycle
were acquired during multiple breath-holds. The endocardial volume of
the left ventricle was quantified from a semi-automatic segmentation (CIM v8.1, University of Auckland). A sensitivity analysis of the CircAdapt model
was performed using the Morris method (r=36 trajectories, p=10 levels and n=23
inputs [4, 5]) to identify the most influencing
parameters. These parameters were then included in an optimization problem to
personalize the cardiac mechanical properties from the minimization of the
difference between the MRI volumes and the CircAdapt estimated volumes (Figure
1). A one-way ANOVA was performed on the optimized parameters to compare the
risk groups.Results
The sensitivity study of the CircAdapt model showed that the left ventricle stiffness (LVS), the left ventricle contractility
(LVC) and the arteriovenous pressure drop (Pdrop) were the most influencing
parameters. No significant differences were observed on LVS and LVC between the
three groups (p>0.05, Figures 2 and 3). However, LVS tends to be smaller
(-10%) while LVC tends to be higher (+10%) in both HR and HRdex groups as
compared to SR and “CircAdapt” healthy groups. Significant differences were
observed on Pdrop between the three groups (p=.048, Figure 4). The HR group
appears to be the closest to the nominal values of 11 mmHg of CircAdapt while
increasing for SR and HRdex groups.Discussion
Both passive and active
mechanical properties of the left ventricle of the SR group, who received the
lowest dose of anthracycline, were expected to be similar to the ones of healthy
volunteers. However, the subtle changes found in the HR group were not expected
to be also found in the HRdex groups who received a cardioprotective agent,
suggesting a lack of effectiveness of the dexrazoxane on the mechanical
properties of the left ventricle. The large increase of the arteriovenous
pressure drop in the HRdex group (three time the nominal value) suggested a
compensation of the functional condition of the heart by the central nervous
system through the peripheral components of the oxygen delivery chain.
Among the 47 patients, only 23
of them showed reliable optimization results (mean volume differences less than
11ml that is the mean difference obtained for the 47 survivors), decreasing the
power of the statistical tests. The CircAdapt model showed limitations in
representing an early systole peak that appears around the 7th frame
(instead of 11th) over 25 frames.Conclusion
Volumes
extracted from cine-MRI images coupled to incremental exercise data allowed the
quantification of the mechanical properties of the left ventricle using a
reverse material identification approach based on the CircAdapt model. While
both passive and active properties did not show significant changes in ALL
survivors between risk groups, the increased arteriovenous pressure drop suggested that the cardioprotective agent
entailed a compensation of the cardiac function through the peripheral
components of the oxygen delivery chain.Acknowledgements
NSERC, Polytechnique Montreal and the Foundation Arbour for the financial support, researchers
from the PETALE study for the opportunity to do this complementary analyses on
the cancer survivors.References
1. Singal, P.K. and N.
Iliskovic, Doxorubicin-Induced
Cardiomyopathy. New England Journal of Medicine, 1998. 339(13): p. 900-905.
2. Chatterjee,
K., et al., Doxorubicin cardiomyopathy.
Cardiology, 2010. 115(2): p. 155-62.
3. Arts,
T., et al., Adaptation to mechanical load
determines shape and properties of heart and circulation: the CircAdapt model.
Am J Physiol Heart Circ Physiol, 2005. 288(4):
p. H1943-54.
4. Morris,
M.D., Factorial Sampling Plans for
Preliminary Computational Experiments. Technometrics, 1991. 33(2): p. 161-174.
5. Campolongo,
F., J. Cariboni, and A. Saltelli, An
effective screening design for sensitivity analysis of large models. Environmental
Modelling & Software, 2007. 22(10):
p. 1509-1518.